ロード中...
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
BACKGROUND: In an era of low local relapse rates after adjuvant breast radiotherapy, risks of late normal-tissue effects (NTE) need to be balanced against risk of relapse. NTE are assessed using patient-reported outcome measures (PROMs), clinician-reported outcomes (CRO) and photographs. This analys...
保存先:
| 出版年: | Radiother Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Scientific Publishers
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486395/ https://ncbi.nlm.nih.gov/pubmed/31005219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2019.01.036 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|